Skip to main content
Generix Group S.A. logo

Generix Group S.A. — Investor Relations & Filings

Ticker · GENX ISIN · FR0010501692 LEI · 9695003QNWHLC60H9E89 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 466 across all filing types
Latest filing 2015-04-10 Declaration of Voting R…
Country FR France
Listing PA GENX

About Generix Group S.A.

https://www.generixgroup.com/en

Generix Group is a global SaaS company that provides a portfolio of AI-powered, cloud-based solutions to streamline mission-critical digital processes in supply chain, finance, and commerce. The company's software suite is designed to help businesses build collaborative digital networks with their trading partners. Key offerings include Warehouse Management Systems (WMS), Transportation Management, B2B Integration, and automated invoice management. By digitizing the flow of goods and data, Generix Group enables organizations to optimize operations, enhance productivity, and manage end-to-end processes from procurement to payment and from order to delivery.

Recent filings

Filing Released Lang Actions
Déclaration de droits de votes et actions au 31 mars 2015
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is dated April 10, 2015, and explicitly references French regulatory articles (Article L. 233-8 II du Code de Commerce and Article 223-16 du règlement général de l'Autorité des Marchés Financiers - AMF). It provides a table detailing the total number of shares and theoretical voting rights as of March 31, 2015. This content directly relates to the official disclosure of voting rights and share capital structure, which aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' (DVA) category, as it is a formal declaration of these figures.
2015-04-10 French
Déclaration de droits de votes et actions au 28 février 2015
Regulatory Filings Classification · 95% confidence The document is dated March 17, 2015, and explicitly references compliance with Article L. 233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers (AMF). The content is a table detailing the 'total number of shares' and 'theoretical voting rights' as of February 28, 2015. This structure is characteristic of a mandatory regulatory disclosure in France regarding the total voting rights, which is often filed as a general regulatory announcement or a specific notice related to capital structure/voting rights. Since there is no specific code for 'Total Voting Rights Disclosure' that fits perfectly, and it is not a full report (like 10-K or IR), nor a director's dealing (DIRS), the closest fit among the provided options that covers mandatory regulatory disclosures not covered elsewhere is RNS (Regulatory Filings). However, given the specific nature of reporting total voting rights, it is a very specific type of regulatory filing. If we strictly adhere to the provided definitions, it is a mandatory regulatory disclosure. It is not a Director's Dealing (DIRS), nor a Share Issue (SHA). It is a periodic disclosure of voting power. RNS is the most appropriate fallback for specific, non-standard regulatory disclosures.
2015-03-17 French
Déclaration de droits de votes et actions au 31 janvier 2015
Regulatory Filings Classification · 95% confidence The document is dated February 6, 2015, and explicitly references French regulatory articles (Article L. 233-8 II of the Commercial Code and Article 223-16 of the AMF General Regulation). It provides a table detailing the total number of shares and theoretical voting rights as of January 31, 2015. This type of mandatory disclosure regarding the total number of shares and voting rights is a specific regulatory filing requirement, often related to capital structure or pre-AGM disclosures. It is not a full Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV). Since it is a specific regulatory disclosure about voting rights/share count that doesn't fit perfectly into AGM-R (which is usually the presentation) or DVA (which is the *result* of a vote), it aligns best with a specific regulatory filing category. Given the content focuses purely on the total number of voting rights, it is most closely related to the mechanics of shareholder voting rights, but since it's a routine regulatory update on the share count, it falls under the general regulatory disclosure category, RNS, as it is a specific regulatory filing not covered by other codes. However, upon re-evaluation against the provided definitions, the content is a direct report of the total number of voting rights, which is a key input for shareholder meetings. Since there is no specific code for 'Total Voting Rights Disclosure', and it is not a DVA (Declaration of Voting Results), RNS (General Regulatory Filing) is the most appropriate fallback for this specific, non-standard regulatory disclosure.
2015-02-06 French
Generix Group : CA Q3 2014/2015
Earnings Release Classification · 98% confidence The document is a press release dated January 26, 2015, announcing the revenue ('chiffre d'affaires') for the third quarter (Q3) of the fiscal year 2014/2015, ending December 31, 2014. It contains detailed, non-audited financial tables showing revenue breakdown by segment (Licenses, Maintenance, SaaS, etc.) and growth rates for the quarter and the nine-month period. This structure is characteristic of an Earnings Release (ER), which provides the initial announcement of periodical financial results, often highlighting key figures before a full report is issued. It is not a comprehensive Annual Report (10-K) or a detailed Interim Report (IR), but rather the initial release of quarterly performance metrics. Q3 2014
2015-01-26 French
Generix Group REV Q3 2014/2015
Earnings Release Classification · 98% confidence The document explicitly states it is announcing 'revenues for the third quarter, ended December 31, 2014, of its financial year 2014/2015.' It presents detailed, period-specific financial figures (revenue by segment, contract signings) and discusses performance trends for a specific quarter (Q3). This structure is characteristic of an Earnings Release (ER), which provides the initial announcement of periodical financial results, often in a press release format, rather than the comprehensive, audited Annual Report (10-K) or the detailed Management Discussion & Analysis (MDA). Since it is a press release format summarizing quarterly results, ER is the most appropriate classification. The document length (5751 chars) is substantial enough to contain key results, but it is not the full, formal regulatory filing. Q3 2014
2015-01-26 English
Generix Group : Succès de l’offre publique de rachat d'actions (OPRA)
Transaction in Own Shares Classification · 99% confidence The document is titled "Succès de l'offre publique de rachat d'actions (OPRA)" and details the results of a share repurchase offer (OPRA). It explicitly states the number of shares bought back, the total amount spent, and the subsequent cancellation of these shares, leading to a change in the total share capital. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category (POS). It is not a general financing announcement (CAP) but a specific report on the completion and outcome of a share repurchase program.
2015-01-22 French

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.